CIK 0001501796 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Aura Biosciences, Inc.
Sign in to watch- Ticker
- AURA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 320271970
- Phone
- (617)500-8864
- Business address
- 80 GUEST STREET, BOSTON, MA, 02135
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-16 | Gibney Anthony S See Remarks | Purchase · Common Stock Warrants (right to buy) | +12,500 | 12,500 | ||
| 2025-04-16 | Elazzouzi Amy Senior Vice President, Finance | Sale | −897 | $5.49 | $5K | 81,381 |
| 2025-04-16 | Kilroy Conor See Remarks | Sale | −7,162 | $5.49 | $39K | 179,313 |
| 2025-03-31 | Bitetti Teresa Marie Director | Grant or award | +21,000 | 21,000 | ||
| 2025-03-31 | Bitetti Teresa Marie Director | Grant or award · Stock Option (Right to Buy) | +29,000 | 29,000 | ||
| 2025-02-18 | Plavsic Mark Chief Technology Officer | Sale | −2,151 | $7.75 | $17K | 209,456 |
| 2025-02-18 | Elazzouzi Amy Senior Vice President, Finance | Sale | −1,404 | $7.75 | $11K | 82,278 |
| 2025-02-18 | Hopkins Janet Jill Chief Medical Officer | Sale | −2,534 | $7.75 | $20K | 269,794 |
| 2025-02-18 | de los Pinos Elisabet See Remarks | Sale | −20,221 | $7.75 | $157K | 482,440 |
| 2025-02-03 | de los Pinos Elisabet See Remarks | Grant or award | +194,320 | 502,661 | ||
| 2025-02-03 | de los Pinos Elisabet See Remarks | Grant or award · Stock Option (Right to Buy) | +255,680 | 255,680 | ||
| 2025-02-03 | Plavsic Mark Chief Technology Officer | Grant or award | +90,475 | 211,607 | ||
| 2025-02-03 | Plavsic Mark Chief Technology Officer | Grant or award · Stock Option (Right to Buy) | +59,525 | 59,525 | ||
| 2025-02-03 | Hopkins Janet Jill Chief Medical Officer | Grant or award | +120,635 | 272,328 | ||
| 2025-02-03 | Hopkins Janet Jill Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +79,365 | 79,365 | ||
| 2025-02-03 | Kilroy Conor See Remarks | Grant or award | +90,475 | 186,475 | ||
| 2025-02-03 | Kilroy Conor See Remarks | Grant or award · Stock Option (Right to Buy) | +59,525 | 59,525 | ||
| 2025-02-03 | Elazzouzi Amy Senior Vice President, Finance | Grant or award | +45,240 | 83,682 | ||
| 2025-02-03 | Elazzouzi Amy Senior Vice President, Finance | Grant or award · Stock Option (Right to Buy) | +29,760 | 29,760 | ||
| 2025-01-21 | de los Pinos Elisabet See Remarks | Sale | −15,955 | $7.67 | $122K | 304,692 |
Page 5 of 11 · 219 trades